首页> 外文期刊>Antimicrobial agents and chemotherapy. >Neisseria gonorrhoeae strain with high-level resistance to spectinomycin due to a novel resistance mechanism (mutated ribosomal protein S5) Verified in Norway
【24h】

Neisseria gonorrhoeae strain with high-level resistance to spectinomycin due to a novel resistance mechanism (mutated ribosomal protein S5) Verified in Norway

机译:由于一种新的耐药机制(变异的核糖体蛋白S5),对淋球菌具有高水平耐药性的淋病奈瑟氏球菌菌株

获取原文
获取原文并翻译 | 示例
           

摘要

Gonorrhea may become untreatable, and new treatment options are essential. Verified resistance to spectinomycin is exceedingly rare. However, we describe a high-level spectinomycin-resistant (MIC, >1,024 g/ml) Neisseria gonorrhoeae strain from Norway with a novel resistance mechanism. The resistance determinant was a deletion of codon 27 (valine) and a K28E alteration in the ribosomal protein 5S. The traditional spectinomycin resistance gene (16S rRNA) was wild type. Despite this exceedingly rare finding, spectinomycin available for treatment of ceftriaxone-resistant urogenital gonorrhea would be very valuable.
机译:淋病可能变得无法治愈,因此必须选择新的治疗方法。经验证的对壮观霉素的耐药性极为罕见。然而,我们描述了一种来自挪威的高水平对壮观霉素(MIC,> 1,024 g / ml)的淋病奈瑟氏球菌菌株,具有新颖的耐药机制。抗性决定因素是核糖体蛋白5S中密码子27(缬氨酸)的缺失和K28E的改变。传统的壮观霉素抗性基因(16S rRNA)是野生型。尽管发现了这一极为罕见的发现,但可用于治疗头孢曲松耐药性泌尿生殖道淋病的壮观霉素仍将是非常有价值的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号